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The surface of all mammalian cells is covered 
by complex carbohydrate structures termed 
glycans (van Kooyk and Rabinovich, 2008). 
The glycan structure is determined by the en-
zymatic processes that produce glycosidic link-
ages of saccharides to other saccharides, and the 
expression profile of these glycan-modifying 
enzymes is altered by several factors, such as 
cell differentiation and activation, inflamma-
tory insults, and the environment (Marth and 
Grewal, 2008; van Kooyk and Rabinovich, 
2008; Baum and Crocker, 2009; Rabinovich and 
Toscano, 2009). Consequently, there is a diverse 
and abundant repertoire of glycan structures on 
the cell surface, which is known as the gly-
come (Marth and Grewal, 2008; van Kooyk and 
Rabinovich, 2008; Rabinovich and Toscano, 
2009). The importance of the glycome in im-
mune responses has been highlighted by its role 
in the control of cell homing, apoptosis, and 
microbial recognition (Marth and Grewal, 2008; 
van Kooyk and Rabinovich, 2008; Baum and 
Crocker, 2009; Rabinovich and Toscano, 2009). 
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Immune responses are modified by a diverse and abundant repertoire of carbohydrate 
structures on the cell surface, which is known as the glycome. In this study, we propose 
that a unique glycome that can be identified through the binding of galectin-4 is created 
on local, but not systemic, memory CD4+ T cells under diverse intestinal inflammatory 
conditions, but not in the healthy state. The colitis-associated glycome (CAG) represents  
an immature core 1–expressing O-glycan. Development of CAG may be mediated by down-
regulation of the expression of core-2 1,6-N-acetylglucosaminyltransferase (C2GnT) 1,  
a key enzyme responsible for the production of core-2 O-glycan branch through addition of 
N-acetylglucosamine (GlcNAc) to a core-1 O-glycan structure. Mechanistically, the CAG 
seems to contribute to super raft formation associated with the immunological synapse on 
colonic memory CD4+ T cells and to the consequent stabilization of protein kinase C  
activation, resulting in the stimulation of memory CD4+ T cell expansion in the inflamed 
intestine. Functionally, CAG-mediated CD4+ T cell expansion contributes to the exacerba-
tion of T cell–mediated experimental intestinal inflammations. Therefore, the CAG may be 
an attractive therapeutic target to specifically suppress the expansion of effector memory 
CD4+ T cells in intestinal inflammation such as that seen in inflammatory bowel disease.
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model (Fig. 1 B). To see whether the intensified galectin-4 
binding on CD4+ T cells is a specific feature of colitis or a 
common feature associated with any inflammatory condi-
tions, we next examined a concanavalin A–induced hepatitis 
model. Interestingly, binding of galectin-4 on CD4+ T cells 
was decreased in the inflamed liver (Fig. 1 B, right).
Galectins are structurally classified into three groups (pro-
totype, chimera type, and tandem-repeat type), and galectin-4 
belongs to the tandem-repeat type (Lowe, 2001; Baum and 
Crocker, 2009; Hsu et al., 2009; Rabinovich and Toscano, 
2009). To test whether the inflammation-inducible binding 
on colonic CD4+ T cells is specific for galectin-4, we used 
another tandem-repeat galectin (galectin-8) and a prototype 
galectin (galectin-3). Unlike galectin-4, there was no differ-
ence in the binding pattern of galectin-8 on CD4+ T cells 
from inflamed versus normal colon (Fig. 1 C, left). The dif-
ferent binding pattern between galectin-4 and -8 may be 
caused by the ability of galectin-8 to interact with more di-
verse arrays of glycan structures as compared with galectin-4 
(Vokhmyanina et al., 2012). In addition, no difference in 
the binding pattern of galectin-3 was observed when CD4+  
T cells from inflamed versus normal colon were examined 
(Fig. 1 C, right). Because galectin-3 interacts with complex 
N-glycans (Lowe, 2001), it is possible that O-glycan, rather 
than N-glycan, on colonic CD4+ T cells is more susceptible 
to inflammation-induced alteration.
As observed in mouse models, CD4+ T cells from the in-
flamed colon of both UC and CD patients also exhibited in-
creased galectin-4 binding in comparison to noninflammatory 
controls (Fig. 1 D). Interestingly, this binding was also ob-
served with CD4+ T cells from the inflamed colon of patients 
with Campylobacter infection (Fig. 1 D). Flow cytometric analy-
sis confirmed a more intensified binding of galectin-4 on 
CD4+ T cells isolated from the inflamed area of UC patients 
as compared with those from noninflamed area (Fig. 1 E). In-
terestingly, in UC patients, galectin-4-binding was rarely ob-
served on CD8+ T cells from the inflamed colon or on CD4+ 
T cells from the peripheral blood (Fig. 1 E), which is consis-
tent with a previous study showing no galectin-4 binding on 
peripheral mononuclear cells (Paclik et al., 2008). Collectively, 
these findings suggest that a common glycome, which can be 
identified by intensified galectin-4 binding, is created on co-
lonic CD4+ T cells under intestinal inflammatory conditions 
in mice and humans.
Decreased C2GnT expression in colitis
Glycome is produced by the coordinated action of glycan-
modifying enzymes (Marth and Grewal, 2008; van Kooyk and 
Rabinovich, 2008; Baum and Crocker, 2009; Rabinovich and 
Toscano, 2009). We therefore performed real-time, PCR-
based preliminary screening to examine the expression profile 
of 63 major glycan-modifying enzymes in purified CD4+  
T cells from inflamed versus normal colon (unpublished data). 
As the result, we found that core-2 1,6-N-acetylglucosami-
nyl transferase (C2GnT) 1 was commonly down-regulated in 
the CD4+ T cells obtained from the inflamed colon of various 
In addition, a recent human genetic study provides support 
for an alteration of the glycome in B cell signaling as a pro-
tective factor in some autoimmune diseases (Surolia et al., 
2010). Therefore, understanding the functional role of each 
glycome motif in the immune response can potentially open 
up a new avenue for the treatment of immune-mediated 
diseases (Rabinovich and Toscano, 2009).
Inflammatory bowel disease (IBD) is a chronic intestinal 
inflammatory condition that develops in a genetically predis-
posed host. IBD is characterized by two major forms, Crohn’s 
disease (CD) and ulcerative colitis (UC), which are medi-
ated by both common and distinct mechanisms (Xavier and 
Podolsky, 2007; Kaser et al., 2010; Mizoguchi and Mizoguchi, 
2010). For example, Th1/Th17 responses have been impli-
cated in the pathogenesis of CD, whereas UC has a signifi-
cant contribution from Th2 cytokines (Xavier and Podolsky, 
2007; Kaser et al., 2010; Mizoguchi and Mizoguchi, 2010). 
However, both diseases are characterized by a significant 
expansion of inflammatory memory CD4+ T cells in the 
inflamed intestine (Xavier and Podolsky, 2007; Kaser et al., 
2010). Although much is known about the pathogenic effec-
tor mechanisms in these diseases, little information is cur-
rently available on how the carbohydrate structure of T cells 
contributes to these responses (Santucci et al., 2003; Hokama 
et al., 2004; Müller et al., 2006; Srikrishna et al., 2005). This 
is in contrast to the abundant amount of information available 
on the heavily O-glycosylated mucus that has been clearly 
demonstrated to play a protective role in IBD (An et al., 2007; 
Stone et al., 2009).
We herein demonstrate a colitis-associated glycome (CAG) 
on CD4+ T cells, which is characterized by immature core-1 
O-glycan and induced through down-regulation of core-2 
1,6-N-acetylglucosaminyltransferase (C2GnT) 1 expres-
sion under intestinal inflammatory conditions. We also 
propose that the inducible glycome motif contributes to the 
exacerbation of colitis by enhancing the expansion of effector 
memory CD4+ T cells through stabilization of protein kinase C 
(PKC)  activation.
RESULTS
Colitis-associated T cell glycome
An endogenous glycan-binding protein family, the galectins, 
is composed of 15 members that recognize different carbohy-
drate epitopes and play different roles (e.g., anti- versus pro-
inflammatory) in immune responses (Lowe, 2001; Baum and 
Crocker, 2009; Hsu et al., 2009; Rabinovich and Toscano, 
2009). We previously demonstrated that an increased binding 
of galectin-4 is specifically seen on CD4+ T cells in the in-
flamed, but not normal, colon of Th2-mediated experimen-
tal colitis model (Hokama et al., 2004). We herein demonstrate 
that the binding of galectin-4 is also intensified on CD4+ 
T cells, but not CD4 cell populations, in the inflamed colon 
of Th1-mediated colitis model (CD45RB model) as compared 
with those in the normal colon of WT mice (Fig. 1 A). In 
contrast, intensified binding of galectin-4 was not observed 
on CD4+ T cells in other tissues (lung and liver) of this colitis 
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glycome (CAG) represents the immature core-1 O-glycan. 
Indeed, an exogenous lectin peanut agglutinin (PNA), which 
interacts specifically with nonsialylated immature core-1 
O-glycan (Toscano et al., 2007), was observed to bind to 
CD4+ T cells derived from the inflamed, but not normal, 
colon (Fig. 2 B). Competition of C2GnT1 and ST3Gal1 
sialyltransferase for sialylation of core-1 O-glycan has previ-
ously been shown to control thymic CD8+ T cell homeosta-
sis (Priatel et al., 2000). Therefore, we next examined the 
expression of ST3Gal-1 in colonic CD4+ T cells. Interestingly, 
no significant change or rather decrease in the ST3Gal1 ex-
pression was observed in colonic CD4+ T cells from inflamed 
colon as compared with those from normal colon (Fig. 2 C), 
suggesting that CAG may be created through a unique O-glycan 
biosynthesis pathway that favors generation of a nonsialy-
lated immature core-1 O-glycan. As observed in mice, down-
regulation of both C2GnT and ST3Gal1 expressions was 
seen in the purified CD4+ T cells from the involved areas 
(colon) in comparison to those obtained from the non-
involved areas of UC patients (Fig. 2 D).
colitis models as compared with CD4+ T cells in the nor-
mal colon of WT mice (Fig. 2 A). The colitis models used 
include Th1-mediated colitis (CD45RB model) that was 
induced in RAG1/ mice by adoptive transfer of CD4+ 
CD45RBhigh naive T cells from WT spleen, Th2-mediated 
colitis that spontaneously develops in TCR/ mice, 
memory T cell–induced colitis that was induced in TCR-
deficient and IL-2–deficient double KO (IL-2 DKO) 
mice by adoptive transfer of CD4+ CD45RBlow memory 
T cells from WT spleen, and acute intestinal injury that 
was induced by oral administration of 4% dextran sulfate 
sodium (DSS) for 4 d (Fig. 2 A).
C2GnT1 represents the key enzyme responsible for the 
production of core-2 O-glycan branch through addition of 
N-acetylglucosamine (GlcNAc) to a core-1 O-glycan struc-
ture (Tsuboi and Fukuda, 1997, 1998; Lowe, 2001). Because 
galectin-4 has previously been demonstrated to interact with 
selected glycomes, such as an immature (nonsialylated) core-1 
O-glycan (Ideo et al., 2002; Blixt et al., 2004), this finding has 
prompted us to develop a hypothesis that colitis-associated 
Figure 1. CAG. (A) Galectin-4 (Gal4) binding patterns on lamina propria cells (including CD4+ versus CD4 cells) in normal colon of WT mice and  
inflamed colon of CD45RB model are shown. Data shown are one representation of seven independent experiments. (B) Intensities of galectin-4 binding 
on CD4+ T cells from the colon, lung, and liver of WT mouse, CD45RB model, and concanavalin A–induced hepatitis model (right panel) are shown.  
The results are representative in 3–12 mice in each group. (C) Intensities of galectin-3 (Gal3) and galectin-8 (Gal8) binding on CD4+ T cells from the colon 
of WT mouse and from the inflamed colon of CD45RB model are shown. The results are representative in 3 mice in each group. (D) Colonic tissues from 
healthy individuals (n = 5) and from patients with UC (n = 6), CD (n = 4), or Campylobacter infection (n = 2) were co-stained with FITC–anti-CD4 (green, 
left) and Alexa Fluor 594–labeled recombinant human galectin-4 (red, middle). Overlap images are shown on the right. Bars, 25 µm. (E) Flow cytometric 
analysis shows the intensity of galectin-4 binding on CD4+ (top) or CD8+ (bottom) T cells from inflamed colon (active, n = 10), noninvolved colon  
(inactive, n = 5), and peripheral blood (PBMC, n = 2) of UC patients and from normal colon of control subjects (normal, n = 4).
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the spleen of WT versus T/C2GnT tg mice and transferred into 
Rag1/ mice lacking T and B cells, and the recipient mice 
were sacrificed at 8 wk after cell transfer. As previously dem-
onstrated (Izcue et al., 2009), the donor T cells from WT mice 
induced the development of severe colitis in the recipients 
(Fig. 3, A and B) and expressed the CAG in the inflamed colon 
(Fig. 2 E). In contrast, CD4+ T cells with restored expression 
of C2GnT were significantly less able to induce the develop-
ment of colitis (Fig. 3, A and B), consistent with their inabil-
ity to express the CAG (Fig. 2 E). As predicted, no colitis was 
found in control WT mice (Fig. 3 A). The disease severity 
was further supported by the colonic expression level of an 
inflammatory cytokine; significantly increased IL-1 expres-
sions were observed in the colon of Rag1/ mice reconsti-
tuted with WT-derived CD4+ T cells as compared with 
those reconstituted with T/C2GnT tg–derived CD4+ T cells 
(Fig. 3 C). These findings demonstrate that ability of CD4+ 
T cells to express CAG is a significant contributor to the 
exacerbation of this naive T cell–induced colitis.
Contribution of CAG for T cell proliferation
In the next series of studies, we examined the effect of CAG 
on colonic CD4+ T cell function during inflammation. We 
first noted that the improvement of colitis observed as a con-
sequence of restored C2GnT expression was associated with 
a significant decrease in the absolute number of CD4+ T cells 
in the colon (Fig. 4 A). Indeed, in comparison to WT-derived 
To test whether the decreased C2GnT expression ob-
served in mouse and human CD4+ T cells in the setting of 
inflammation is responsible for the development of CAG, 
we next restored C2GnT expression in CD4+ T cells by using 
T cell–specific C2GnT transgenic (T/C2GnT tg) mice that 
lack surface expression of core-1 O-glycan because of forced 
expression of this enzyme (Tsuboi and Fukuda, 1997, 1998). 
Indeed, PNA and galectin-4 were unable to bind to the 
C2GnT-expressing CD4+ T cells in the inflamed colon (Fig. 2 E, 
right). In addition, the restoration of C2GnT expression sup-
pressed the binding of Maackia amurensis lectin II (MALII), 
which is capable of interacting with both sialylated and non-
sialylated core 1 O-glycans (Geisler and Jarvis, 2011). Interest-
ingly, binding of Helix pomatia lectin (HPA) and Lycopersicon 
esculentum lectin (LEL), which interact with other glycan struc-
tures, was intensified under inflammatory condition. How-
ever, the intensified binding on colonic CD4+ T cells was not 
suppressed by restoration of C2GnT expression (Fig. 2 E). 
Collectively, these findings suggest that down-regulation of 
C2GnT expression during inflammation is responsible for 
the generation of CAG recognized by galectin-4.
Pathogenic role of CAG in colitis of CD45RB model
To examine whether the expression of CAG on CD4+  
T cells plays any role in colitis, we examined a naive T cell–
induced colitis model (CD45RB model; Izcue et al., 2009). 
In brief, CD4+CD45RBhigh naive T cells were purified from 
Figure 2. Development of CAG by down-
regulation of C2GnT expressions. (A) Expres-
sion levels of C2GnT1 in purified CD4+ T cells 
from the normal colon of WT mice and from 
the inflamed colon of four kinds of colitis 
models were examined by real-time PCR.  
The colitis models include TCR/ mice,  
DSS model, CD45RB model, and IL-2 DKO 
model. n = 6–7/each group. *, P < 0.001.  
(B) Binding intensities of PNA on colonic CD4+  
T cells from WT mice, TCR/ mice,  
and CD45RB model are shown. The results  
are one representation of 3–5 independent 
experiments. (C) Expression levels of ST3Gal1 
in purified CD4+ T cells from the normal colon 
of WT mice and from the inflamed colon of 
TCR/ mice, CD45RB model, and IL-2 DKO 
model are shown. The results are representa-
tive in 6–8 mice in each group. *, P < 0.005. 
(D) Expression levels of C2GnT and ST3Gal1 in 
purified CD4+ T cells from noninflamed colon 
(inactive, n = 6) and from inflamed colon 
(active, n = 6) of UC patients are shown.  
**, P < 0.005; *, P < 0.05. (E) FACS analysis shows 
the binding intensities of galectin-4, PNA, MalII, 
HPA, and LEL on colonic CD4+ T cells from WT 
mice (as control, left) and from recipient 
Rag1/ mice that were reconstituted with 
WT-derived (middle) versus C2GnT tg–derived 
(right) naive T cells. The data are one repre-
sentation of three independent experiments.
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These findings propose that the expression of CAG directly 
contributes to the enhancement of colonic CD4+ T cell ex-
pansion under intestinal inflammatory condition.
Deleterious effect of CAG on memory T cell–induced colitis
A previous study has suggested that the initial priming of 
T cells necessary for maturation from naive to memory stages 
is impaired in T/C2GnT tg mice (Tsuboi and Fukuda, 1998). 
This finding raised a possibility that the decreased prolifera-
tion/expansion observed in T cells from T/C2GnT tg mice, 
and, consequently, protection from colitis, was a result of in-
sufficient priming of the adoptively transferred naive T cells. 
To test this possibility, we next used another mouse model 
system in which colitis can be induced by adoptive transfer 
of memory CD4+ T cells (Nagahama et al., 2008). In brief, 
CD4+ CD45RBlow memory T cells were purified from the 
spleen of WT versus T/C2GnT tg mice, and they were adop-
tively transferred into TCR and IL-2 DKO mice.
As previously demonstrated (Nagahama et al., 2008), 
WT memory CD4+ T cells induced severe colitis in the re-
cipient mice at 8 wk after cell transfer (Fig. 5, A and C), 
CD4+ T cells, T/C2GnT tg–derived CD4+ T cells exhibited 
significantly less proliferation as judged by BrdU incorpora-
tion (Fig. 4, B and C).
It was possible that the decreased CD4+ T cell–proliferation 
observed was a secondary phenomenon associated with the 
improvement of colitis. Therefore, we next used a co-transfer 
system to clarify whether absence of CAG directly dampens 
the ability of CD4+ T cells to proliferate. To do so, CD4+ 
T cells were purified from a reporter mouse strain in which all 
cells are genetically engineered to express GFP (Shimomura 
et al., 2008) and from T/C2GnT tg mice. Both cell popula-
tions were then co-transferred at a 1:1 ratio into Rag1/ 
mice. As predicted, the recipient mice developed severe coli-
tis at 8 wk after co-transfer (unpublished data). Interestingly, 
in the same individual recipient colon, the GFP+ CD4+ 
(WT-derived) T cells were observed to proliferate more vig-
orously than the GFP CD4+ (C2GnT tg–derived) T cells 
(Fig. 4, D and E).
To rule out the potential possibility that GFP expres-
sion, per se, influenced the outcome, T/C2GnT tg mice 
were next engineered to express GFP. Equal numbers of puri-
fied CD4+ T cells from WT mice and from GFP-expressing 
T/C2GnT tg mice were then co-transferred into Rag1/ 
mice. As shown in Fig. 4 F, we observed that GFP CD4+ 
(WT-derived) T cells exhibited significantly greater prolifer-
ation than seen in GFP+ CD4+ (C2GnT tg–derived) T cells. 
Figure 3. Pathogenic role of CAG in colitis of CD45RB model. 
CD4+CD45RBhigh naive T cells were purified from the spleen of WT 
(WT>RAG) versus T/C2GnT Tg (C2GnT>RAG) mice, and they were adop-
tively transferred i.v. into Rag1/ mice. The recipients were sacrificed at 
8 wk after transfer. (A) Representative colonic histologies (×10 objective) 
are shown. Colon of donor WT mouse is shown as normal control. Bars, 
200 µm. (B) Disease scores evaluated by a combination of macroscopic 
and microscopic examinations are summarized. Each dot represents  
individual recipient. **, P < 0.0001. (C) Expression levels of IL-1 in the 
colonic tissues from WT mice and from Rag1/ mice with transfer of 
WT-derived (WT>RAG) versus T/C2GnT tg–derived (C2GnT>RAG) CD4+  
T cells are shown. n = 6/each group. *, P < 0.005.
Figure 4. Effect of CAG on CD4+ T cell expansion. (A–C) 
CD4+CD45RBhigh naive T cells were purified from the spleen of WT 
(WT>RAG, n = 15) versus T/C2GnT Tg (C2GnT>RAG, n = 26) mice, and 
they were adoptively transferred i.v. into Rag1/ mice. The recipients 
were sacrificed at 8 wk after transfer. Absolute numbers of colonic CD4+  
T cells in the recipient colon are shown in A. Proliferative responses as 
judged by BrdU incorporation in the colonic CD4+ T cells are shown in B. 
The absolute number of colonic BrdU+ CD4+ T cells is summarized in C.  
(D and E) Purified CD4+CD45RBhigh T cells from the spleen of GFP Tg ver-
sus C2GnT Tg mice were co-transferred into Rag1/ mice. The prolifera-
tive response of reconstituted GFP+ CD4+ (WT-derived) versus GFPCD4+ 
(C2GnT tg–derived) cells in the same recipient colon are shown in  
(D; n = 5). The mean of the percentage of BrdU+ cells in the GFP+ versus 
GFP CD4+ T cells is summarized in E. (F) Purified CD4+CD45RBhigh T cells 
from the spleen of WT versus GFP-expressing C2GnT double Tg mice were 
co-transferred into Rag1/ mice. The proliferative response of reconsti-
tuted GFP CD4+ (WT-derived) versus GFP+CD4+ (C2GnT tg–derived) cells 
in the same recipient colon are shown. Data shown are one representa-
tion of three independent experiments. *, P < 0.01; **, P < 0.0001.
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right panel). These findings suggest that CAG, which is 
expressed on memory CD4+ T cells, has the ability to ex-
acerbate colitis.
Effect of CAG on memory T cell proliferation
Consistent with the colitis severity, absolute numbers (Fig. 6 A) 
and proliferative responses (Fig. 6 B) of colonic CD4+ T cells 
were significantly lower in IL-2 DKO recipient mice that 
received C2GnT tg–derived memory CD4+ T cells in com-
parison to those mice that received WT-derived memory 
CD4+ T cells. Co-transfer experiments of memory CD4+  
T cells from GFP-reporter mice and from T/C2GnT tg 
mice into IL-2 DKO mice confirmed that WT-derived mem-
ory T cells (GFP+) were more proliferative than C2GnT tg–
derived memory T cells (GFP) when examined in the same 
colons (Fig. 6 C). Another set of co-transfer experiments using 
memory CD4+ T cells from WT mice and from GFP-expressing 
T/C2GnT tg mice further confirmed the higher proliferative 
ability of WT-derived memory CD4+ T cells (GFP) as com-
pared with C2GnT tg–derived memory CD4+ T cells (GFP+) 
in the same individual colon of IL-2 DKO mouse (Fig. 6 D).
To test whether CAG promotes the expansion of se-
lected T helper (Th) subset, colonic cells from IL-2 DKO 
mice reconstituted with C2GnT tg–derived versus WT-
derived memory CD4+ T cells were stimulated ex vivo with 
phorbor-12,13-dibutylate/ionomycin and subjected to intra-
cellular staining of IFN-, IL-17A, IL-10, and IL-4. In-
terestingly, although absolute number of CD4+ T cells in 
the inflamed colon was significantly reduced by restoration 
of C2GnT expression (Fig. 6 E, left), there was no propor-
tional difference in Th1 (IFN-), Th17 (IL-17A), Tr1 (IL-10), 
and Th2 (IL-4) subsets among the colonic CD4+ T cell 
population (Fig. 6 E). Indeed, restoration of C2GnT ex-
pression did not alter the expression level of T-bet, RORt, 
GATA3, or c-Maf in the purified colonic CD4+ T cells 
(Fig. 6 F). Collectively, these findings demonstrate the ability 
of CAG to directly enhance the proliferative response of 
memory CD4+ T cells but not the differentiation of spe-
cific Th subsets.
Contribution of CAG to raft integrity
Galectin-4 has previously been demonstrated to stabilize 
lipid rafts on epithelial cells for generation of super rafts 
(Braccia et al., 2003). The immunological synapse (IS), which 
is built on the lipid raft characterized by detergent insolu-
bility, serves as a key component providing signals for 
T cell stimulation and proliferation (Xavier et al., 1998; 
Arendt et al., 2002). We therefore biochemically determined 
whether galectin-4 binds to lipid rafts associated with the 
IS. In brief, purified CD4+ T cells were obtained from the 
inflamed colon, lysed as previously described (Xavier et al., 
1998), and precipitated with galectin-4–coupled beads. 
The precipitants were then subjected to analysis with a liquid 
chromatography tandem mass spectrometry. The protein 
complex precipitated by galectin-4 included formin-like 1, 
vinculin, actin-polymerization Arpc3, and Rab11, all of 
and the reconstituted donor CD4+ T cells in the recipi-
ent colon all exhibited memory phenotype (Fig. 5 D). 
The development of severe colitis was further supported 
by the increased expression of colonic IL-1 (Fig. 5 E). 
Similar to the results obtained with adoptive transfer 
of naive T cells, CAG was observed on the memory- 
derived donor CD4+ T cells in the recipient colon (Fig. 5 F, 
middle panel). In contrast, T/C2GnT tg–derived memory 
CD4+ T cells induced significantly less severe colitis 
(Fig. 5 B and C), and they did not express CAG (Fig. 5 F, 
Figure 5. Pathogenic role of CAG in memory CD4+ T cell-mediated 
colitis. CD4+CD45RBlow memory T cells were purified from the spleen of 
WT (WT>IL2, n = 20) versus T/C2GnT Tg (C2GnT>IL2, n = 18) mice, and 
they were adoptively transferred i.v. into IL-2 DKO mice. The recipients 
were sacrificed at 8 wk after T cell transfer. (A and B) Representative his-
tology of recipient colons with transfer of WT (A) versus C2GnT Tg (B) 
CD4+ T cells are shown. Bars, 200 µm. (C) The disease scores are summa-
rized. (D) Flow cytometric analysis shows the expressions of CD4 versus 
CD62L on splenic cells of WT mouse (left panel, as control) and colonic 
lamina propria cells from recipient IL-2 DKO mice after transfer of 
memory CD4+ T cells from the spleen of WT (middle panel) or C2GnT tg 
(right panel) mice. Data are representative in 3 independent experiments. 
(E) Expression levels of IL-1 in colonic tissues from WT mice and from 
IL-2 DKO mice with transfer of WT-derived (WT>IL2, n = 6) versus  
T/C2GnT tg–derived (C2GnT>IL2, n = 6) CD4+ T cells are shown.  
(F) Binding intensities of galectin-4 (Gal4) on colonic CD4+ T cells in WT 
mice (left, as control) and the recipients with transfer of WT-derived 
(middle) versus C2GnT Tg–derived (right) memory CD4+ T cells are shown. 
Data shown are one representation of five independent experiments.  
**, P < 0.0001; *, P < 0.005.
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Sustained PKC activation through CAG
PKC, which represents a proximal molecule in IS-mediated 
signaling, exists diffusely within the cytoplasm of resting 
CD4+ T cells and is accumulated within the IS after TCR 
activation (Arendt et al., 2002). Therefore, we next exam-
ined whether absence of CAG altered the inflammation-
induced activation of PKC. To do so, CD4+ T cells were 
purified from the inflamed colon of IL-2 DKO mice 
with transfer of WT versus C2GnT tg–derived memory 
CD4+ T cells. After cell lysis, lipid rafts were precipitated 
with CT-coupled beads, and the precipitant subjected to 
immune-blot with an anti-PKC antibody. As shown in 
Fig. 7 C (top), more PKC could be detected in association 
with the precipitated detergent-insoluble lipid rafts obtained 
from the fresh WT-derived CD4+ T cells in comparison to 
that observed from the C2GnT-expressing CD4+ T cells. 
Coomassie blue staining of the precipitates showed that this 
was not caused by differences in the quantity of proteins 
(Fig. 7 C, bottom).
An in vitro approach was next conducted to confirm 
these in vivo data. To do so, purified CD4+ T cells from the 
which have been identified to localize within the IS (Gomez 
et al., 2007; Nolz et al., 2007). Interestingly, galectin-4 also 
precipitated Fam62a (five-C2 domain-containing protein); 
we confirmed Fam62a has accumulated within the IS by 
confocal microscopy (Fig. 7 A). These findings indicate 
that galectin-4 interacts with CAG in the detergent-insoluble 
region of the cell membrane (lipid raft) that is in association 
with the IS.
We next examined whether the lack of CAG alters the 
formation of lipid raft/IS. To do so, CD4+ T cells from 
GFP mice and T/C2GnT tg mice were co-transferred into 
IL-2 DKO mice, and the binding of cholera toxin (CT; 
a marker of lipid rafts) to the GFP+ (WT-derived) versus 
GFP (T/C2GnT tg–derived) CD4+ T cells from the same 
inflamed colon was examined by flow cytometry. Interest-
ingly, significantly more intense binding of CT was observed 
on WT-derived CD4+ T cells in comparison to that observed 
on the cell surface of T/C2GnT-derived CD4+ T cells 
(Fig. 7 B). These findings propose a contribution of CAG in 
the generation of super rafts on CD4+ T cells during the 
course of intestinal inflammation.
Figure 6. CAG-mediated stimulation of 
memory CD4+ T cell proliferation. (A and B) 
CD4+CD45RBlow memory T cells were purified 
from the spleen of WT (WT>IL2) versus  
T/C2GnT Tg (C2GnT>IL2) mice, and they were 
adoptively transferred i.v. into IL-2 DKO 
mice. The recipients were sacrificed at 8 wk 
after T cell transfer. (A) Absolute numbers of 
colonic CD4+ T cells in the recipient are 
shown. Each dot represents an individual 
mouse. (B) Proliferative responses of colonic 
CD4+ T cells are shown. The absolute numbers 
of BrdU+CD4+ in the colon is summarized in 
right panel. (C) Purified CD4+CD45RBlow mem-
ory T cells from the spleen of GFP Tg versus 
C2GnT Tg mice were co-transferred into IL-2 
DKO mice. The proliferative response of re-
constituted GFP+ CD4+ (WT-derived) versus 
GFP CD4+ (C2GnT tg–derived) cells in the 
same recipient colon are shown. Right panel 
summarizes the average of percentages (n = 5) 
of BrdU+ cells in GFP+ versus GFP CD4+  
T cells. (D) Purified CD4+CD45RBlow memory  
T cells from the spleen of WT versus GFP-
expressing C2GnT-expressing double Tg mice 
were co-transferred into IL-2 DKO mice. The 
proliferative response of reconstituted GFP 
CD4+ (WT-derived) versus GFP+CD4+ (C2GnT 
tg–derived) cells in the same recipient colon 
are shown. (E) Left panels show the propor-
tion of CD3+CD4+ T cells in the colonic lamina 
propria cells of recipient IL-2 DKO mice re-
constituted with WT-derived (WT>IL2) ver-
sus T/C2GnT tg–derived (C2GnT>IL2) memory CD4+ T cells. The proportion of IL-4, IFN-, IL-17A, and IL-10–producing cells in the colonic CD4+ T cell 
population is then examined after ex vivo stimulation. Data shown are one representation of three independent experiments. (F) Expression levels of  
T-bet, GATA3, c-Maf, and RORt in purified CD4+ T cells from the colon of WT mice (white bars, n = 6) and of IL-2 DKO mice reconstituted with  
WT-derived (gray bars, n = 19) versus T/C2GnT tg–derived (black bars, n = 13) memory CD4+ T cells are shown. *, P < 0.01; **, P < 0.0001.
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reduced when galectin-4 was omitted from the culture 
(Fig. 8, B and C).
We next examined whether the sustained proliferative 
response through development of CAG depends on PKC. 
To do so, colonic CD4+ T cells used in Fig. 8 B were pre-
treated with rotterin (an inhibitor of Ca2+-dependent PKC 
including PKC). As shown in Fig. 8 D, inhibition of PKC 
suppressed the galectin-4/CAG-induced proliferative re-
sponse of colonic CD4+ T cells (Fig. 8 D, top right). In con-
trast, pretreatment with KT5720 (an inhibitor of PKA) had 
no effect on the proliferative response (Fig. 8 D, top left). In 
addition, these treatments did not alter the galectin-4 binding 
on the CD4+ T cells (Fig. 8 D, bottom). To further confirm 
the in vitro finding, in vivo co-transfer experiment using 
PKC/ mice (Sun et al., 2000) was next conducted. To do so, 
CD4+CD45RBlow memory T cells were purified from the 
spleen of PKC/ mice versus GFP-reporter mice, and they 
were co-transferred into IL-2 DKO mice. In the same indi-
vidual recipient colon, PKC-intact and PKC-deficient 
CD4+ T cells both developed CAG (Fig. 8 E). However, 
PKC-deficient CD4+ T cells (as indicated by GFP), despite 
expressing CAG, exhibited significantly less proliferative 
response as compared with PKC-intact CD4+ T cells (as in-
dicated by GFP+; Fig. 8 F). Collectively, these findings suggest 
that CAG-mediated expansion of memory CD4+ T cells de-
pends on the activation of PKC.
DISCUSSION
In this manuscript, we propose that an inducible CAG, which 
can be identified by galectin-4 binding, is created on local 
memory CD4+ T cells under diverse intestinal inflamma-
tory conditions that range from IBD to infection but not in 
inflamed colon were stimulated for 30 min with anti-CD3 
and anti-CD28–coupled magnetic beads. After removal of 
the beads, the activated cells were cultured again in the pres-
ence of galectin-4 for 1 or 3 h, and then lysed. The accumu-
lation of PKC within the lipid rafts was then assessed as 
described in Fig. 7 C. Interestingly, at 3 h after stimulation, 
activation of PKC (as indicated by the association within 
CT-precipitated lipid rafts) was lower in C2GnT tg–derived 
CD4+ T cells in comparison to WT-derived CD4+ T cells 
(Fig. 7 D, right). Indeed, significant capping of PKC was 
observed on the WT-derived CD4+ T cells as compared with 
C2GnT tg–derived CD4+ T cells (Fig. 7 E). In contrast, such 
differences in PKC activation were not detectable between 
CD4+ T cells from WT and C2GnT tg mice at 1 h after 
stimulation (Fig. 7 D, left). These findings suggest that CAG 
has the ability to sustain, but not initiate, the activation of 
PKC in colonic memory CD4+ T cells.
PKC-dependent proliferation of CAG-expressing T cells
In a final set of experiments, we examined whether the sus-
tained PKC activation in colonic CD4+ T cells by CAG de-
velopment promotes the proliferative response. To do so, 
colonic memory CD4+ T cells were stimulated as shown in 
Fig. 7 D, and the activated cells were cultured again in the 
presence of galectin-4 for 1 or 3 h. At 1 h before analysis, 
cells were pulsed with BrdU. As shown in Fig. 8 (A and C), 
similar levels of proliferation were observed in WT- versus 
C2GnT tg–derived CD4+ T cells at 1 h after stimulation. 
However, at 3 h after stimulation, much less proliferation was 
seen in C2GnT tg–derived CD4+ T cells compared with 
WT-derived CD4+ T cells (Fig. 8, B and C). In addition, the 
proliferative response of WT-derived CD4+ T cells was 
Figure 7. Contribution of CAG for stabilization 
of PKC activity, (A) Purified CD4+ T cells from 
the inflamed colon were stained with anti-PKC 
(green, left) and ant-Fam62a (red, middle)  
antibodies. The merge image is shown on the right.  
Data shown are one representation of three 3 inde-
pendent experiments. Bars, 15 µm. (B) Memory CD4+ 
T cells from GFP tg mice and T/C2GnT tg mice were 
co-transferred into IL-2 DKO mice, and the intensity 
of CT-binding on GFP+ (line) versus GFP (solid) CD4+ 
T cells from the same recipient colon was examined. 
Data shown are one representation of three indepen-
dent experiments. (C–E) CD4+ T cells (Fresh in C) were 
purified from the colon of recipient IL-2 DKO mice 
with transfer of WT-derived versus C2GnT Tg 
(C2GnT)–derived memory CD4+ T cells. Purified CD4+ 
T cells were stimulated with ant-CD3/CD28 coated 
beads, and after removal of beads they were cultured 
again in the presence of galectin-4 for 1 (1 h in D) 
and 3 h (3 h in D). Lipid rafts were precipitated using 
CT-coupled beads and subjected to detection of PKC 
(top). The bottom panels show the Coomassie blue 
staining of total protein subjected to CT-precipitation. The CD4+ T cells cultured for 3 h were stained with anti-PKC antibodies and subjected to confocal 
microscopic analysis (E). Bars, 15 µm. Data shown are one representation of three independent experiments.
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characteristic CAG is detectable that is functionally associated 
with promoting the inflammatory process. Therefore, intesti-
nal inflammatory insults may further modify the Th-specific 
glycomes, creating a local inflammation-specific glycome. 
Interestingly, unlike intestinal inflammation, hepatic inflam-
mation did not induce the development of CAG. Because 
host–microbial interaction is significantly enhanced in intes-
tinal, but not hepatic, inflammation (Sartor, 2008), this raises 
a possibility that some microbial-derived factors may contrib-
ute to the development of CAG.
We show that the CAG can be recognized by galectin-4 
that has previously been shown to interact with specific car-
bohydrate epitopes such as an immature (nonsialylated) core-1 
O-glycan (Ideo et al., 2002; Blixt et al., 2004). In addition, 
we show that CAG development was abolished by restora-
tion of C2GnT expression, an enzyme responsible for initiat-
ing the maturation (branching) of O-glycans from core-1 to 
core-2 (Tsuboi and Fukuda, 1997, 1998). Collectively, these 
findings propose that the CAG observed reflects an immature 
core-1 O-glycan caused by a down-regulation of expression 
of the responsible enzyme during inflammation from a vari-
ety of different causes. An important observation in our study 
is that the CAG observed on CD4+ T cells contributes sig-
nificantly to the exacerbation, but not induction, of colitis. 
The data would thus indicate that impairment of O-glycan 
maturation in CD4+ T cells plays a deleterious role for 
progression of colitis and supports a previous notion that 
N-glycan maturation (branching) can safeguard against some 
autoimmune diseases (Green et al., 2007). Consistent with 
this, galectin-4, which interacts with immature glycan struc-
tures (Ideo et al., 2002; Blixt et al., 2004), has been shown to 
exacerbate an experimental chronic colitis (Hokama et al., 2004). 
In contrast, galectins-1 and -3, which interact with more ma-
ture glycan structures (Lowe, 2001; Baum and Crocker, 2009), 
contribute to the suppression of colitis (Santucci et al., 2003; 
Müller et al., 2006). Thus, during the course of inflamma-
tion, changes in the glycan structures that decorate patho-
genic memory T cells results in alterations in cell surface 
interactions that further control intestinal inflammation. 
Alternatively, administration of galectin-4 delayed the recov-
ery from DSS-induced colitis (Hokama et al., 2004), whereas 
the administration ameliorated the acute phase of this colitis 
(Paclik et al., 2008). DSS-induced acute colitis is mediated 
by innate immune response, and adaptive immune responses 
then participate in the recovery process from this colitis 
(Mizoguchi, 2012). Therefore, it is possible that the role of 
galectin-4 in colitis differs depending on innate versus adap-
tive immune responses involved. This possibility is supported 
by a recent report demonstrating the ability of galectin-4 to 
suppress innate immune response by killing blood group 
antigen-expressing bacteria (Stowell et al., 2010).
Galectin-4 has previously been demonstrated to promote 
the formation of super rafts on non–T cells (Braccia et al., 2003). 
Here, we propose that CAG, which interacts with galectin-4, 
contributes to super raft formation on colonic CD4+ T cells, 
leading to prolonged IS-mediated activation. In support of 
healthy state. This CAG is characterized by the formation 
of an immature core-1–containing O-glycan, presumably 
through the loss of a C2GnT enzyme involved in the addi-
tion of N-acetylgalactosamine to create a core-2 O-glycan. 
It has been previously shown that CD4+ T cell subsets, 
including Th1, Th2, and Th17 express different glycomes 
depending on the cytokine profile (Toscano et al., 2007). 
Alternatively, as shown here, during intestinal inflammation 
from a variety of different causes and mechanistic pathways, a 
Figure 8. Requirement of PKC for CAG-mediated proliferation. 
(A-C) Purified colonic CD4+ T cells from IL-2 DKO mice with reconstitu-
tion of WT-derived (WT>IL2) versus T/C2GnT tg–derived (C2GnT>IL2) 
memory CD4+ T cells were stimulated with anti-CD3/CD28–coated beads, 
and after removal of beads they were cultured again in the presence or 
absence of galectin-4 for 1 (A) and 3 h (B). They were pulsed with BrdU  
1 h before the analysis and subjected to flow cytometric analysis. The 
percentage of BrdU+ cells is summarized in C. *, P < 0.01 (n = 4–7).  
(D) Purified colonic CD4+ T cells from IL-2 DKO mice with reconstitution of 
WT-derived (WT>IL2) versus T/C2GnT tg–derived (C2GnT>IL2) memory 
CD4+ T cells were pretreated with KT5720 (left) or rotterin (right), and 
they were then stimulated with anti-CD3/CD28–coated beads. After re-
moval of beads, they were cultured in the presence of galectin-4 for 3 h, 
with 1-h pulse with BrdU, and subjected to flow cytometric analysis for 
evaluation of BrdU incorporation (top) and galectin-4 binding (bottom). 
Data shown are one representation of two independent experiments.  
(E and F) Purified CD4+CD45RBlow memory T cells from the spleen of GFP 
Tg versus PKC/ mice were co-transferred into IL-2 DKO mice. The 
intensity of galectin-4 binding on (E) and the proliferative response of  
(F) reconstituted GFP+ CD4+ (PKC-intact) versus GFP CD4+ (PKC-deficient) 
cells in the same recipient colon are shown. The mean (n = 4) of percent-
ages of BrdU+ cells in GFP+ (PKC-intact) versus GFP (PKC-deficient) 
CD4+ T cells are summarized in G. *, P < 0.01.
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Hospital. All experiments were approved by the subcommittee on Research 
Animal Care of Massachusetts General Hospital.
Human samples. Diagnosis for IBD was based on conventional clinical 
and endoscopic criteria. Surgically rejected or biopsy specimens were ob-
tained with informed consent from patients who had active or inactive UC, 
active CD, Campylobacter infection, or polyps (as healthy control). All experi-
ments were approved by local Ethics Committees of Shiga University of 
Medical Science and Keio University School of Medicine.
Induction and evaluation of colitis. For CD45RB model, T cells 
were first enriched from the spleen using T cell enrichment column 
(R&D Systems). After staining with FITC–anti-CD4 and PE–anti-CD45RB 
mAbs, CD4+CD45RBhigh T cells were purified using flow cytometric 
sorting. The purity was >98%. CD4+CD45RBhigh T cells (5 × 105) were 
intravenously administrated into Rag1/ mice, and the recipients were eu-
thanized at 8 wk after cell transfer. For memory CD4+ T cell–induced colitis 
model, T cells enriched through T cell–enrichment column were stained 
with FITC–anti-CD4 and PE–anti-CD45RB mAbs, and CD4+CD45RBlow 
T cells were then purified using flow cytometric sorting. The purity was 
>99%. CD4+CD45RBlow T cells (5 × 105) were intravenously administrated 
into IL-2 DKO mice, and the recipients were euthanized at 8 wk after 
cell transfer. The disease score of both models was assessed by a combination 
of gross and histological examinations as previously described (Nagahama 
et al., 2008).
Cell isolation and flow cytometric analysis. In humans, lamina propria 
mononuclear cells were isolated as previously described (Okazawa et al., 
2002; Kamada et al., 2008). In brief, dissected mucosa was incubated with 
30 mM EDTA for 20 min, followed by incubation in medium containing 
1.5 mg/ml collagenase type IV (Sigma-Aldrich) and 0.1 mg/ml DNaseI 
(Roche) for 60 min at 37°C. After passing glass wool column, cells were 
subjected to Ficoll density gradient, and CD4+ cells were magnetically 
separated using iMag CD4 MicroBeads (BD). Colonic LP cells from mice 
were isolated as previously described (Shimomura et al., 2008). They were 
blocked, stained, and analyzed using FACSCalibur (BD) and FlowJo soft-
ware (Tree Star). For mice, FITC–anti-CD3 (clone 145-2C11; BD), 
PE–anti-CD4 (clone RM4-4; eBioscience), FITC-PNA (Vector Laboratories), 
Biotinylated-MALII (Vector Laboratories)/Alexa Fluor 488–conjugated 
streptavidin (Invitrogen), Alexa Fluor 488–HPA (Invitrogen), and FITC-
LEL (Vector Laboratories) were used. For humans, Alexa Fluor 488–human 
galectin-4, APC-anti–human CD4 (clone RPA-T4; BD), and APC-anti–human 
CD8 (clone SK1; BD) were used.
Recombinant galectins. Human and mouse recombinant galectin-4 and 
galectin-3 were generated previously (Hokama et al., 2004). Full-length 
cDNA of mouse galectin-8 was synthesized by GenScript Inc. and subcloned 
into pGEX-6P vector (GE Healthcare). BL-21 stain carrying pGEX-6P was 
cultured in the presence of 0.1 mM IPTG. Fusion protein was purified with 
glutathione Sepharose 4B, and recombinant protein was separated from the 
GST moiety by using PreScission protease (GE Healthcare). After removal 
of endotoxin using endotoxin removal gel (Thermo Fisher Scientific), the 
protein was dialyzed to PBS and concentrated. 1 mg of galectin was labeled 
with Alexa Fluor 488 or Alexa Fluor 594 according to the manufacture’s in-
struction (Invitrogen).
Confocal microscopic analysis. Human colon tissues were snap-frozen 
in O.C.T. compound, and 5 µm (in thickness) cryosections were prepared. 
After fixation with acetone for 5 min at 4°C and subsequent blocking with 
2% BSA and 1% gelatin, sections were subjected to double staining with 
Alexa Fluor 594–conjugated recombinant galectin-4 and FITC-conjugated 
anti–human CD4 (BioLegend). The staining was analyzed using FV1000 
confocal laser microscopy (Olympus) immediately after immunostaining.
For mouse cells, purified CD4+ T cells were incubated with rabbit anti-
Fam62a antibody, which was generated by help from Affinity BioReagents. 
this, we show that formation of CAG led to sustained acti-
vation of PKC; a key proximal element in the IS-induced 
signaling machinery (Arendt et al., 2002). PKC is primarily 
responsible for the activation and proliferation of memory, 
but not naive, CD4+ T cells through consequent NF-B1 
activation (Sun et al., 2000). In addition, we have previ-
ously demonstrated that absence of PKC suppresses both 
Th1 and Th2 responses in the inflamed colon by reducing 
memory CD4+ T cell proliferation rather than by inhibit-
ing the differentiation of naive T cells into Th1, Th17, or 
Th2 cells (Nagahama et al., 2008). Consistent with this, we 
herein show that the absence of CAG suppressed the pro-
liferative responses of colonic memory CD4+ T cells, but 
it did not affect the differentiation of Th subsets in the in-
flamed colon. Therefore, our studies propose that forma-
tion of CAG serves to sustain PKC activation, resulting in 
enhanced expansion of memory CD4+ T cells in the inflamed 
colon. However, our current dataset may be unable to rule 
out a possibility that an alteration of retention/homing of 
CD4+ T cells is also involved in the CAG-mediated expan-
sion in the inflamed colon.
PKC has been proposed as an attractive therapeutic tar-
get in IBD (Baier and Wagner, 2009). PKC-mediated sig-
naling leading to consequent activation of NF-B is used 
primarily by memory CD4+ T cells but not by naive CD4+ 
T cells, CD8+ T cells, or other cell types (Arendt et al., 2002; 
Kingeter and Schaefer, 2008). This is consistent with our ob-
servations that CAG is expressed by memory CD4+ T cells in 
the inflamed colon but not in other organs associated with 
models of colitis (Hokama et al., 2004). Interestingly, a recent 
study has suggested that PKC is not recruited to the IS of 
CD4+ Foxp3+ regulatory T cells, but rather inhibits the regu-
latory function of these cells (Zanin-Zhorov et al., 2010). 
Thus, collectively, blockade of CAG formation for inhibi-
tion of PKC activity may represent a specific therapeutic 
strategy to target colitogenic memory CD4+ T cells with-
out affecting other T cell populations.
In summary, we propose that intestinal inflammation is as-
sociated with the formation of an inducible colitis-associated 
glycome (CAG) on local memory CD4+ T cells, which con-
tributes to the exacerbation of intestinal inflammation, pre-
sumably by stimulating their expansion through prolonged 
PKC activation. This mechanistic pathway may provide a 
rationale to specifically target effector memory CD4+ T cells 
in the inflamed intestine.
MATERIALS AND METHODS
Mice. Sperm of a transgenic mouse stain carrying human C2GnT gene 
under control of Lck promoter (Tsuboi and Fukuda, 1997) was obtained from 
M. Fukuda (Burnham Institute, San Diego, CA), and the mice were recov-
ered through in vitro fertilization with the help of Charles River Laboratory. 
The recovered T cell–specific C2GnT (T/C2GnT) tg mice were further 
backcrossed to C57BL/6 mice five times. GFP tg, Tcr/, Il-10/, Rag1/, 
and Tcr-IL-2 DKO) mice were C57BL/6 background (Nagahama et al., 
2008; Shimomura et al., 2008). GFP-expressing T/C2GnT tg mice were 
generated by crossing T/C2GnT tg mice with GFP tg mice. All mice were 
maintained under specific pathogen–free facility at Massachusetts General 
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